US Patent 10189823 Neprilysin inhibitors
Patent 10189823 was granted and assigned to Theravance on January, 2019 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10189823 Neprilysin inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
